Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Christopher Peter
Christopher Peter Jones, Weston Super Mare GB
| Patent application number | Description | Published |
|---|---|---|
| 20100147765 | METHOD OF TREATING LIQUID WASTE - A method of treating a liquid waste containing target species is described, in which the liquid is first conveyed through a housing containing a catalyst for removing either a reducing agent or an oxidising agent from the liquid, The liquid is then conveyed to a reverse osmosis or nanofiltration membrane to obtain a retentate rich in the target species and a permeate lean in the target species. The retentate is returned to the liquid upstream from the membrane, whilst the permeate may be subject to further treatment, for example in a neutralisation plant. | 06-17-2010 |
Christopher Peter Jones, Swindon GB
| Patent application number | Description | Published |
|---|---|---|
| 20080245667 | Electromembrane Process and Apparatus - Apparatus is described for removing ionisable impurities from an electrolyte solution in an electromembrane device. The apparatus comprises means for recirculating the electrolyte solution between the cathode and the anode, and means for transferring selected ions from the electrolyte solution into a separate stream upon application of a current. | 10-09-2008 |
| 20100139481 | METHOD OF TREATING A GAS SYSTEM - In a method of treating a gas stream, an aqueous scrubbing liquor is circulated through an essentially closed loop ( | 06-10-2010 |
Christopher Peter Wayman, Sandwich GB
| Patent application number | Description | Published |
|---|---|---|
| 20090175793 | TREATMENT OF MALE SEXUAL DYSFUNCTION - A composition comprising a selective oxytocin antagonist for use in the treatment and/or prevention of a male ejaculatory disorder; which selective oxytocin antagonist is optionally admixed with a pharmaceutically acceptable carrier, diluent or excipient. | 07-09-2009 |
| 20110107442 | Treatment of Male Sexual Dysfunction - A composition comprising a selective oxytocin antagonist for use in the treatment and/or prevention of a male ejaculatory disorder; which selective oxytocin antagonist is optionally admixed with a pharmaceutically acceptable carrier, diluent or excipient. | 05-05-2011 |